Puma Biotechnology (PBYI) Other Operating Expenses (2011 - 2026)

Puma Biotechnology's Other Operating Expenses history runs 12 years deep, the most recent figure standing at $10.4 million for Q1 2026.

• Quarterly Other Operating Expenses fell 1.25% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.0 million (down 9.66% YoY) and the FY2025 annual result came in at $58.2 million, down 9.7% from the prior year.
• Other Operating Expenses was $10.4 million for Q1 2026 at Puma Biotechnology, down from $23.1 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $29.1 million in Q3 2024 and bottomed at $10.4 million in Q1 2026.
• A 5-year average of $15.4 million and a median of $13.2 million in 2023 frame the typical range for Other Operating Expenses.
• Peak annual rise in Other Operating Expenses reached 131.03% in 2022, while the deepest fall reached 63.31% in 2022.
• Puma Biotechnology's Other Operating Expenses stood at $16.8 million in 2022, then jumped by 44.47% to $24.3 million in 2023, then slumped by 42.77% to $13.9 million in 2024, then surged by 66.13% to $23.1 million in 2025, then tumbled by 54.93% to $10.4 million in 2026.
• Business Quant data shows PBYI's Other Operating Expenses at $10.4 million in Q1 2026, $23.1 million in Q4 2025, and $12.2 million in Q3 2025.